Related Experiment Video

Updated: Aug 16, 2026

Assays for the Degradation of Misfolded Proteins in Cells
10:56

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016

Inclusion body myositis: abnormal protein accumulation does not trigger apoptosis

D O Hutchinson1

  • 1Department of Neurology, Auckland Hospital, New Zealand.

Neurology
|December 17, 1998
PubMed

Insights

Apoptosis, or programmed cell death, is unlikely to cause muscle fiber loss in inclusion body myositis. Studies comparing inclusion body myositis and polymyositis found minimal DNA fragmentation in non-necrotic muscle fibers.

Area of Science:

  • Neurology
  • Cell Biology
  • Pathology

Background:

  • Inclusion body myositis (IBM) is a progressive neuromuscular disorder characterized by muscle weakness and atrophy.
  • The precise mechanisms driving muscle fiber loss in IBM remain incompletely understood.
  • Apoptosis, a form of programmed cell death, has been investigated as a potential contributor to muscle degeneration.

Purpose of the Study:

  • To investigate the role of apoptosis in muscle fiber loss in inclusion body myositis (IBM).
  • To compare the frequency of DNA fragmentation (a marker of apoptosis) in muscle samples from IBM patients and polymyositis (PM) patients.

Main Methods:

  • Utilized the terminal deoxynucleotidyl transferase-mediated X-dUTP nick-end labeling (TUNEL) assay.
  • Analyzed muscle biopsy samples from patients diagnosed with inclusion body myositis and polymyositis.
  • Quantified TUNEL-positive nuclei in non-necrotic muscle fibers, necrotic muscle fibers, and mononuclear cells.

Main Results:

  • TUNEL-positive nuclei were rare in non-necrotic muscle fibers of IBM patients, even near amyloid deposits.
  • DNA fragmentation was significantly less frequent in IBM compared to polymyositis.
  • Apoptotic markers were considerably less frequent than necrotic muscle fibers or myocytotoxicity in both patient groups.

Conclusions:

  • Apoptosis is unlikely to be a major driver of muscle fiber loss in the pathogenesis of inclusion body myositis.
  • The findings suggest that other mechanisms, such as necrosis or immune-mediated cell destruction, may play a more significant role in IBM.
  • Further research is warranted to elucidate the specific pathways involved in IBM pathology.

More Related Videos

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells11:12

Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells

Published on: October 4, 2017

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...